Tier D · Preclinical / highly limited human evidence
MOTS-c
A fascinating mitochondrial signal with strong scientific interest but no established human treatment benefit.
Why researchers care
Potential human relevance
- Links mitochondrial signaling to glucose metabolism and cellular stress responses
- Human studies show exercise-related changes in circulating MOTS-c biology
- Preclinical models suggest metabolic and exercise-capacity effects
What the human evidence says
Evidence, not extrapolation
Most therapeutic claims remain preclinical. Human data are largely biomarker and physiology studies rather than trials proving that administered MOTS-c improves health outcomes.
How to think about it
The Yooper Peptides take
MOTS-c is scientifically exciting because it is encoded by mitochondrial DNA. That novelty should not be confused with proven clinical efficacy.
Primary / authoritative reading